Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

1.9K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.9K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

602
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
602
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

421
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
421
Drug Dosage Regimen: Overview01:15

Drug Dosage Regimen: Overview

4.7K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
4.7K
Angina IV: Management01:26

Angina IV: Management

439
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
439
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

588
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
588

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy, safety, and tolerability of low sodium oxybate for nocturnal cluster headache attacks in chronic cluster headache: protocol for a phase II randomized, double-blind, placebo-controlled, trial (SUNCET).

Pain management·2026
Same author

[Painful hands and swollen fingers due to fluoride: voriconazole-induced periostitis].

Nederlands tijdschrift voor geneeskunde·2025
Same author

Female- and age-specific reference values for blood pressure and its relationship with cardiac aberrations after pre-eclampsia.

European journal of preventive cardiology·2025
Same author

Efficacy of Anti-PD-(L)1 Immunotherapy in Patients with DNA Mismatch Repair-deficient Metastatic Castration-resistant Prostate Cancer.

European urology oncology·2025
Same author

Palbociclib Is Safe for Breast Cancer Patients With Mild Hepatic Impairment: A Multicenter Retrospective Study Using Real-World Data.

Clinical pharmacology and therapeutics·2025
Same author

[Systemic side effects of locally administered corticosteroids].

Nederlands tijdschrift voor geneeskunde·2024

Related Experiment Video

Updated: Apr 12, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

15.2K

[Choosing wisely when prescribing statins].

Annelieke E C A B Willemsen1, S J H Bas Bredie, Claudia M Lobo

  • 1Radboudumc, Nijmegen.

Nederlands Tijdschrift Voor Geneeskunde
|May 21, 2015
PubMed
Summary

Generic atorvastatin offers a cost-effective alternative to rosuvastatin for cardiovascular risk management, achieving similar LDL targets. While rosuvastatin offers greater LDL reduction, atorvastatin is generally sufficient and significantly cheaper.

More Related Videos

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

26.6K
LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

14.3K

Related Experiment Videos

Last Updated: Apr 12, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

15.2K
A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

26.6K
LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

14.3K

Area of Science:

  • Pharmacoeconomics
  • Cardiovascular Medicine
  • Clinical Pharmacy

Background:

  • The 'Verstandig kiezen' campaign promotes healthcare quality and cost control, adapting the 'Choosing wisely' initiative.
  • Statins, specifically atorvastatin and rosuvastatin, are key in cardiovascular risk management, with guidelines often deeming them equivalent.
  • Cost-effectiveness in statin selection is a growing concern in healthcare.

Purpose of the Study:

  • To evaluate the comparative cost-effectiveness and clinical utility of atorvastatin versus rosuvastatin.
  • To inform clinical decision-making regarding statin choice for cardiovascular risk management.
  • To align with healthcare quality improvement and cost containment goals.

Main Methods:

  • Comparative analysis of efficacy (LDL reduction) and cost between atorvastatin and rosuvastatin.
  • Review of existing clinical guidelines and pharmacokinetic interaction data.
  • Consideration of patient-level factors for treatment selection.

Main Results:

  • Generic atorvastatin is approximately 25 times cheaper than rosuvastatin at equipotent doses.
  • While rosuvastatin offers superior LDL reduction, atorvastatin is typically sufficient to reach patient LDL targets.
  • No significant group-level differences in adverse events were observed between the two statins.

Conclusions:

  • Atorvastatin is recommended as the preferred statin over rosuvastatin when LDL targets are not met with simvastatin, due to its cost-effectiveness.
  • Rosuvastatin may be considered under specific circumstances, necessitating individual patient evaluation of efficacy and adverse effects.
  • Informed patient communication is crucial when switching statin medications to ensure compliance and satisfaction.